Chengbo Yu Selected Research

Chengbo Yu Research Topics

4	Infections 07/2019 - 01/2013
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 07/2016
3	Chronic Hepatitis B 01/2021 - 05/2015
3	Hepatitis B 01/2017 - 11/2015
2	Neoplasms (Cancer) 01/2022 - 10/2016
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Liver Neoplasms (Liver Cancer) 12/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2015
1	Virus Diseases (Viral Diseases) 11/2015
1	Hepatitis C 11/2015
1	Acute Liver Failure (Fulminant Hepatic Failure) 09/2011
1	Liver Diseases (Liver Disease) 09/2011

4	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 01/2013
1	Cytotoxins (Cytolysins)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2021
1	CreatinineIBA 01/2021
1	Tenofovir (Viread)FDA Link 01/2021
1	entecavir FDA Link 01/2021
1	Coffee FDA Link 12/2016
1	Protein Glutamine gamma Glutamyltransferase 2IBA 10/2016
1	Long Noncoding RNAIBA 07/2016
1	HLA-DP Antigens (HLA-DP)IBA 12/2015
1	HLA-DPB1 antigen (HLA DPB1)IBA 12/2015
1	InterferonsIBA 05/2015
1	Interleukin-23 (Interleukin 23)IBA 05/2015

2	Therapeutics 01/2022 - 05/2015
1	Blood Transfusion (Blood Transfusions) 01/2017
1	Body Piercing (Piercing, Body) 11/2015
1	Artificial Liver (Bioartificial Liver) 09/2011
1	Bioreactors (Bioreactor) 09/2011